TITLE

Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation

AUTHOR(S)
Motohashi, K; Fujisawa, S; Onizuka, M; Kako, S; Sakaida, E; Shono, K; Tatara, R; Doki, N; Mori, T; Sakura, T; Aotsuka, N; Fuji, E; Tomita, N; Kawai, N; Saitoh, T; Usuki, K; Taguchi, J; Watanabe, R; Kobayashi, S; Yano, S
PUB. DATE
November 2015
SOURCE
Bone Marrow Transplantation;Nov2015, Vol. 50 Issue 11, p1476
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article analyses the effect of the order of total body irradiation (TBI) and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation. Topics discussed include retrospective study to analyse the transplant outcomes of patients with acute myeloid leukaemia (AML), analysing five-year relapse rates among standard-risk patients with the help of multivariate analysis, and irradiation method.
ACCESSION #
110690558

 

Related Articles

  • Busulfan or TBI: answer to an age-old question. Champlin, Richard E. // Autocar;12/ 2/2013, p3856 

    The author discusses aspects of two studies on the comparison of busulfan and total body irradiation (TBI) for hematopoietic transplantation as therapy for acute myeloid leukemia (AML). He states that intravenous busulfan has been used instead of oral formulation in preparative regimens for...

  • Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AML. Hospital, M A; Thomas, X; Castaigne, S; Raffoux, E; Pautas, C; Gardin, C; Bourhis, J-H; Reman, O; de Revel, T; Terré, C; Preudhomme, C; Fenaux, P; Michallet, M; Socié, G; Dombret, H // Bone Marrow Transplantation;Nov2012, Vol. 47 Issue 11, p1436 

    To illustrate methodological issues, we compared donor vs no-donor to transplant vs no-transplant comparisons in a cohort of 107 patients aged 50 years with adverse karyotype AML in first CR. Adverse karyotypes were defined as −7, del(7q), −5, del(5q), t(9;22), 11q23, 3q26 or...

  • HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1. Venstrom, Jeffrey M.; Pittari, Gianfranco; Gooley, Ted A.; Chewning, Joseph H.; Spellman, Stephen; Haagenson, Michael; Gallagher, Meighan M.; Malkki, Mari; Petersdorf, Effie; Dupont, Bo; Hsu, Katharine C. // New England Journal of Medicine;8/30/2012, Vol. 367 Issue 9, p805 

    Background: Of the cancers treated with allogeneic hematopoietic stem-cell transplantation (HSCT), acute myeloid leukemia (AML) is most sensitive to natural killer (NK)�cell reactivity. The activating killer-cell immunoglobulin-like receptor (KIR) 2DS1 has ligand specificity for HLA-C2...

  • Relapse post hematopoietic SCT remains the Achilles heel for the field. Frangoul, H; Jagasia, M // Bone Marrow Transplantation;Aug2014, Vol. 49 Issue 8, p997 

    The author reflects on the study of N. Bejanyan and colleagues regarding the clinical results of acute myeloid leukemia (AML) patients who experienced relaspe after umbilical cord blood transplant. Topics discussed include the challenges of treating post-transplant relapse, the U.S. National...

  • Inadvertent transplantation of haematopoietic stem cells carrying constitutional Robertsonian translocation from an apparently normal donor to an AML patient: a case report. Consoli, C.; Leotta, S.; Tambè, L.; Di Marco, A. L.; Avola, G.; Camuglia, M. G.; Di Mercurio, S.; Poidomani, M.; Milone, G. // Bone Marrow Transplantation;Sep2011, Vol. 46 Issue 9, p1278 

    A letter to the editor is presented which discusses a case study on haematopoietic stem cells (HSCs) transplantation with Robertsonian translocations (RTs) from a donor to an acute myeloid leukemia (AML) patient.

  • Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Copelan, Edward A.; Hamilton, Betty K.; Avalos, Belinda; Ahn, Kwang Woo; Bolwell, Brian J.; Xiaochun Zhu; Aljurf, Mahmoud; Besien, Koen van; Bredeson, Christopher; Cahn, Jean-Yves; Costa, Luciano J.; Lima, Marcos de; Gale, Robert Peter; Hale, Gregory A.; Halter, Joerg; Hamadani, Mehdi; Inamoto, Yoshihiro; Kamble, Rammurti T.; Litzow, Mark R.; Loren, Alison W. // Autocar;12/ 2/2013, p3863 

    Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the most widely used myeloablative conditioning regimens for allotransplants. Recent data regarding their comparative effectiveness are lacking. We analyzed data from the Center for International Blood and...

  • Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome. Nagler, A; Labopin, M; Berger, R; Bunjes, D; Campos, A; Socié, G; Kröger, N; Goker, H; Yakoub-Agha, I; Shimoni, A; Mohty, M; Rocha, V // Bone Marrow Transplantation;May2014, Vol. 49 Issue 5, p628 

    I.v. BU is frequently used in the conditioning regimen prior to allogeneic hematopoietic SCT (allo-HSCT); however, overall outcomes, incidence of hepatic sinusoidal obstructive syndrome (SOS) and its risk factors are not well known. With this aim, we performed a study on 257 AML adult...

  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Luger, S M; Ringdén, O; Zhang, M-J; Pérez, W S; Bishop, M R; Bornhauser, M; Bredeson, C N; Cairo, M S; Copelan, E A; Gale, R P; Giralt, S A; Gulbas, Z; Gupta, V; Hale, G A; Lazarus, H M; Lewis, V A; Lill, M C; McCarthy, P L; Weisdorf, D J; Pulsipher, M A // Bone Marrow Transplantation;Feb2012, Vol. 47 Issue 2, p203 

    Although reduced-intensity conditioning (RIC) and non-myeloablative (NMA)-conditioning regimens have been used for over a decade, their relative efficacy vs myeloablative (MA) approaches to allogeneic hematopoietic cell transplantation in patients with AML and myelodysplasia (MDS) is unknown. We...

  • Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Kindwall-Keller, T L; Hegerfeldt, Y; Meyerson, H J; Margevicius, S; Fu, P; van Heeckeren, W; Lazarus, H M; Cooper, B W; Gerson, S L; Barr, P; Tse, W W; Curtis, C; Fanning, L R; Creger, R J; Carlson-Barko, J M; Laughlin, M J // Bone Marrow Transplantation;Jul2012, Vol. 47 Issue 7, p924 

    As the threshold nucleated cell dose for one-unit umbilical cord blood (UCB) in adults has not to date been firmly established, we prospectively compared one- vs two-unit UCB transplantation after reduced intensity conditioning (RIC) in adult patients with hematological malignancies. Study...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics